NDC 59088-180

Zintrexyl-C

Ferrous Fumarate, Folic Acid

Zintrexyl-C is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Puretek Corporation. The primary component is Vitamin A Acetate; Ascorbic Acid; Cholecalciferol; .alpha.-tocopherol Acetate, Dl-; Thiamine Mononitrate; Riboflavin; Niacinamide; Pyridoxine Hydrochloride; Folic Acid; Cyanocobalamin; Biotin; Pantothenic Acid; Calcium Carbonate; Ferrous Fumarate; Potassium Iodide; Magnesium Oxide; Zinc Oxide; Selenium; Cuprous Oxide; Manganese Sulfate; Chromium Nicotinate; Molybdenum; Potassium Chloride; Boron.

Product ID59088-180_bb1492c5-bfca-d632-e053-2a95a90ad7d1
NDC59088-180
Product TypeHuman Prescription Drug
Proprietary NameZintrexyl-C
Generic NameFerrous Fumarate, Folic Acid
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-02-11
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NamePureTek Corporation
Substance NameVITAMIN A ACETATE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, DL-; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; BIOTIN; PANTOTHENIC ACID; CALCIUM CARBONATE; FERROUS FUMARATE; POTASSIUM IODIDE; MAGNESIUM OXIDE; ZINC OXIDE; SELENIUM; CUPROUS OXIDE; MANGANESE SULFATE; CHROMIUM NICOTINATE; MOLYBDENUM; POTASSIUM CHLORIDE; BORON
Active Ingredient Strength1500 ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; ug/1; mg/1; ug/1
Pharm ClassesVitamin A [CS],Vitamin A [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC],Nicotinic Acid [EPC],Nicotinic Acids [CS],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 59088-180-58

60 TABLET in 1 BOTTLE, PLASTIC (59088-180-58)
Marketing Start Date2021-02-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Zintrexyl-C" or generic name "Ferrous Fumarate, Folic Acid"

NDCBrand NameGeneric Name
59088-180Zintrexyl-CFerrous Fumarate, Folic Acid
59088-181Folitin-ZFerrous Fumarate, Folic Acid
59088-166PrenatrixFerrous Fumarate, Folic Acid
59088-169PrenatrylFerrous Fumarate, Folic Acid
59088-178PretrateFerrous Fumarate, Folic Acid
59088-172PrometaFerrous Fumarate, Folic Acid
59088-182Ribotin-EFerrous Fumarate, Folic Acid
59088-177Venexa FEFerrous Fumarate, Folic Acid
59088-173Vitranol FeFerrous Fumarate, Folic Acid
59088-168Vitrexate FEFerrous Fumarate, Folic Acid
59088-165Vitrexyl plus IronFerrous Fumarate, Folic Acid

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.